TickerFacts.

Idexx Laboratories Inc (IDXX): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$1.51B
Year ended 2025-12-31
$1.61B
Trailing 12 months to 2026-06-30
+14.2%
3-year compound annual growth
+13.7%
5-year compound annual growth
+15.1%
10-year compound annual growth
2008-12-31: $220.44M2009-12-31: $225.74M2010-12-31: $249.84M2011-12-31: $284.43M2012-12-31: $314.97M2013-12-31: $321.36M2014-12-31: $319.14M2015-12-31: $368.87M2016-12-31: $428.46M2017-12-31: $496.17M2018-12-31: $574.51M2019-12-31: $640.86M2020-12-31: $790.52M2021-12-31: $1.04B2022-12-31: $1.01B2023-12-31: $1.21B2024-12-31: $1.26B2025-12-31: $1.51B$1.51B
2008-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$1.51B+19.6%2026-02-20, From 2025-01-01
2024-12-31$1.26B+3.8%2026-02-20, From 2024-01-01
2023-12-31$1.21B+19.9%2026-02-20, From 2023-01-01
2022-12-31$1.01B-2.5%2025-02-21, From 2022-01-01
2021-12-31$1.04B+31.1%2024-02-22, From 2021-01-01
2020-12-31$790.52M+23.4%2023-02-16, From 2020-01-01
2019-12-31$640.86M+11.5%2022-02-16, From 2019-01-01
2018-12-31$574.51M+15.8%2021-02-12, From 2018-01-01
2017-12-31$496.17M+15.8%2020-02-14, From 2017-01-01
2016-12-31$428.46M+16.2%2019-02-15, From 2016-01-01
2015-12-31$368.87M+15.6%2018-02-16, From 2015-01-01
2014-12-31$319.14M-0.7%2017-02-17, From 2014-01-01
2013-12-31$321.36M+2.0%2016-02-17, From 2013-01-01
2012-12-31$314.97M+10.7%2015-02-17, From 2012-01-01
2011-12-31$284.43M+13.8%2014-02-18, From 2011-01-01
2010-12-31$249.84M+10.7%2013-02-19, From 2010-01-01
2009-12-31$225.74M+2.4%2012-02-17, From 2009-01-01
2008-12-31$220.44Mn/a2011-02-22, From 2008-01-01

EBITDA at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Idexx Laboratories Inc (IDXX)2025-12-31$1.51B+19.6%
QuidelOrtho Corp (QDEL)2025-12-28-$477.20Mn/m
Lantheus Holdings, Inc. (LNTH)2025-12-31$380.93M-27.0%
Neogen Corp (NEOG)2026-05-31$94.70Mn/m
Myriad Genetics Inc (MYGN)2025-12-31-$333.50Mn/m
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$431.22Mn/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$10.63Mn/m
Immucell Corp (ICCC)2025-12-31$4.43M+306.8%
Aspira Women's Health Inc. (AWHL)2025-12-31-$7.80Mn/m

Compare IDXX, QDEL, LNTH, NEOG side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗